Edit |   |
---|---|
Antigenic Specificity | CD22 (biosimilar) |
Clone | hL22 (Epratuzumab) |
Host Species | Recombinant |
Reactive Species | human, primate |
Isotype | IgG1 kappa |
Format | unconjugated |
Size | 0.2 mg |
Concentration | batch dependent |
Applications | Blocking, FC, IP |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | CD22 Biosimilar Antibody |
Immunogen | This antibody was prepared by the humanization of LL2 (EPB-2), a murine anti-CD22 IgG2a raised against Raji Burkitt lymphoma cells. Murine sequences comprise 5-10% of the molecule, with the remainder being human framework sequences, which greatly reduces the potential for immunogenicity (Traczewski, 2010). |
Other Names | Leu14, B-cell receptor CD22, B-lymphocyte cell adhesion molecule, BL-CAM, Sialic acid-binding Ig-like lectin 2, Siglec-2, T-cell surface antigen Leu-14 |
Gene, Accession # | UniProt: P20273 |
Catalog # | orb1671892 |
Price | $888 |
Order / More Info | CD22 (biosimilar) Antibody from BIORBYT LTD. |
Product Specific References | n/a |
U.S. OFFICE
Biorbyt LLC
1100 Corporate Square Drive
Helix Center, Suite 221
St Louis, MO 63132
Email: info@biorbyt.com
Phone: +1 (415) 906-5211
Fax: +1 (415) 651-8558